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Synaptic communication requires constant adjustments of pre- and postsynaptic
efficacies. In addition to synaptic long term plasticity, the presynaptic machinery underlies
homeostatic regulations which prevent out of range transmitter release. In this minireview
we will discuss the relevance of selected presynaptic mechanisms to epilepsy including
voltage- and ligand-gated ion channels as well as cannabinoid and adenosine receptor
signaling.
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INTRODUCTION
Many studies highlighted the importance of homeostasis in neu-
ronal signaling either within neurons, then called “intrinsic plas-
ticity” or between neurons, referred to as “synaptic scaling” (Davis
and Bezprozvanny, 2001; Eichler and Meier, 2008; Turrigiano,
2011). Classic synaptic plasticity in its non-homeostatic “Heb-
bian” form and pathological disturbances need counterbalancing
homeostatic scaling mechanisms (Abbott and Nelson, 2000). The
latter was mainly regarded from the postsynaptic perspective
(Thiagarajan et al., 2005; Groth et al., 2011). However, in addition
to presynaptic expression of synaptic long term plasticity (Nicoll
and Schmitz, 2005), slow homeostatic regulations occur in the
presynapse, e.g., in form of chronic receptor or ion channel
modulations.
PRESYNAPTIC ION CHANNEL AND GLYCINE RECEPTOR
PLASTICITY
Because transmitter release is controlled by action potential-
(AP)-triggered calcium influx in the synaptic terminal, regula-
tion of ion channels which shape the axonal AP and terminal
depolarization is an effective mechanism of presynaptic plas-
ticity. With this definition, the AP initiation zone (AIZ) could
be viewed as part of the presynaptic equipment. A striking
form of homeostatic plasticity has been documented for the
AIZ: this entire subcellular structure including voltage-gated Na+
(Nav) and K+ (Kv) channels can be shifted along the axon
(Figure 1), thereby counteracting hyperexcitation by increasing
thresholds for AP generation (Grubb and Burrone, 2010). Such
axonal remodeling may be facilitated via ion channel trafficking
regulated by alternative splicing, as shown for “shaw-related”
Kv3 channels (Gu et al., 2012). Other important constituents
of presynaptic control are “shaker-related” KV 1 channels (Wang
et al., 1994). Their role is well demonstrated for the large glu-
tamatergic mossy fiber boutons of dentate granule cells, which
impinge on hippocampal CA3 pyramidal cells (Geiger and Jonas,
2000; Bischofberger et al., 2006). Here, Kv channels could gain
further importance during temporal lobe epilepsy (TLE), when
seizures invade the hippocampus and feedforward inhibition of
CA3 pyramidal cells via interneurons is compromised (Lawrence
and McBain, 2003). Indeed, seizures trigger a transcriptional
upregulation of Kv1.1 channels in granule cells, thereby delaying
their AP responses considerably, as recently shown in a TLE
mouse model (Kirchheim et al., 2013). Consistent with the view
that KV 1.1 is a promising antiepileptic target, KV 1.1 knockout
mice develop epilepsy (Wenzel et al., 2007) and lentiviral over-
expression of KV 1.1 ameliorates seizures in an animal model
of neocortical epilepsy (Wykes et al., 2012). The interaction of
activity-dependent downscaling and potentiation of presynaptic
excitability may involve the adenylyl cyclase pathway (Nicoll
and Schmitz, 2005) but it is still unclear how exactly these
seemingly opposed mechanisms interact in the same presynaptic
compartment.
Epilepsy often comes with cognitive dysfunction and neu-
ropsychiatric comorbidities (García-Morales et al., 2008). We
discovered a molecule which in this regard may have an important
impact: an RNA variant of the neurotransmitter receptor for
glycine (GlyR). The GlyRs are subject to increased RNA editing
in resected hippocampi of TLE patients (Eichler et al., 2008)
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FIGURE 1 | Scheme depicting strategic molecules relevant for
homeostasis of presynaptic function and epilepsy discussed in this
minireview. In glutamatergic neurons, gain-of-function of molecules colored
red/orange will increase network excitability, whereas those colored green will
decrease it. The opposite holds true if the changes occur in GABAergic
neurons. Abbreviations: NaV , CaV , KV , voltage-gated sodium, calcium and
potassium channels; AIZ, action potential (AP) initiation zone; GlyR, glycine
receptors; A1, adenosine receptor; CB1, cannabinoid receptor 1.
which profoundly influences biophysical receptor properties. The
reason is an amino acid substitution in the ligand binding domain
leading to gain-of-function receptors with increased neurotrans-
mitter affinity (Meier et al., 2005; Eichler et al., 2008; Legendre
et al., 2009) and spontaneous channel activity (Kletke et al.,
2013; Winkelmann et al., 2014). In addition, RNA splicing gov-
erns presynaptic GlyR expression (Winkelmann et al., 2014),
and in hippocampal neurons, the lack of the GlyR β subunit
(Weltzien et al., 2012) which governs postsynaptic receptor clus-
tering (Meyer et al., 1995; Meier et al., 2000, 2001; Eichler
et al., 2009; Förstera et al., 2010; Kowalczyk et al., 2013), cer-
tainly facilitates GlyR expression and function at presynapses
(Figure 1). Presynaptic GlyRs are tightly packed (∼200 receptor
channels in a cluster with ∼100 nm radius; Notelaers et al., 2012,
2014a,b), which implies that a single presynaptic cluster from the
spontaneously active GlyR RNA variant will have a considerable
functional impact on synaptic neurotransmitter release, even if
the contribution of the glycinergic system to this brain region
appears limited (Zeilhofer et al., 2005). Consistent with the exci-
tatory nature of presynaptic chloride channels and the well docu-
mented presynaptic GlyR expression in the hippocampus (Kubota
et al., 2010; Ruiz et al., 2010; Waseem and Fedorovich, 2010;
Winkelmann et al., 2014), we found that the spontaneously active
GlyR RNA variant actually increased presynaptic excitability and
the functional impact of glutamatergic neurons or parvalbumin-
positive interneurons in vivo and, depending on the type of
neuron, triggered cognitive dysfunction or anxiety in our mouse
model of epilepsy (Winkelmann et al., 2014). In agreement with
the proposed critical role of presynaptic GlyRs in the regulation
of neural network excitability, application of a low, non-receptor-
saturating, glycine concentration (10 µM) to corticohippocampal
slice preparations was sufficient to enhance epileptiform activity
induced by block of KV 1 channels (Chen et al., 2014).
RETROGRADE AUTOCRINE AND PARACRINE SIGNALING
Although the idea of cannabis as a potential antiepileptic drug
is ancient, it remained elusive how it could work reliably
(Adams and Martin, 1996; Miller, 2013). Recent discoveries on
endogenous cannabinoid receptors (CB), of which particularly
CB1 is widely expressed in presynaptic terminals of excita-
tory and inhibitory neurons (Figure 1), could lead to a better
understanding of CB mechanisms in epilepsy (Alger, 2004;
Katona and Freund, 2008; Hill et al., 2012). In GABAergic neu-
rons, activation of CB1, e.g., via neuronal activity-dependent ret-
rograde post-to-presynapse release of CBs anandamide or 2-AG
has been shown to decrease synaptic GABA release, a mechanism
termed depolarization-induced suppression of inhibition (DSI;
Ohno-Shosaku et al., 2001; Wilson et al., 2001). Consistently, ele-
vated CB1 presence observed in epilepsy models and TLE patients
(Goffin et al., 2011; Karlócai et al., 2011; Bojnik et al., 2012) has
been interpreted as proconvulsive (Chen et al., 2003, 2007). On
the other hand, CB1 is also expressed on glutamatergic termi-
nals, where its activation reduces glutamate release (Domenici
et al., 2006; Kawamura et al., 2006). Furthermore, CB1 activa-
tion increases inward rectifier K+ (Kir) currents (Mackie et al.,
1995; Chemin et al., 2001) mediated via postsynaptic channels
which are also upregulated in TLE (Young et al., 2009; Stegen
et al., 2012). In summary, while elevation of CB1 at GABAergic
synapses and reduction at glutamatergic synapses likely constitute
endogenous adaptations to epilepsy, exogenous CB1 overexpres-
sion and activation in principal neurons, possibly via receptors
physiologically rarely activated, could effectively protect against
seizures (Blair et al., 2006; Guggenhuber et al., 2010; Hofmann
and Frazier, 2013).
Adenosine triphosphate (ATP) is released from astrocytes
and can enhance neuronal excitability through its direct action
onto purinergic receptors. However, ATP can also exert indirect
effects upon its enzymatic conversion to adenosine and signaling
through adenosine A1 receptors, which reduces synaptic gluta-
mate release (Nicoll and Schmitz, 2005; Boison, 2013; Dias et al.,
2013). Therefore, adenosine signaling is another mechanism of
presynaptic homeostasis with recognized relevance to epilepsy;
while too much adenosine clearance via gliosis-enhanced adeno-
sine kinase activity is a proconvulsive factor, adenosine augmen-
tation in the epileptic focus represents a powerful anticonvulsive
principle (Boison, 2012).
PERSPECTIVE
In agreement with the proposed critical role of presynaptic
compartments in the regulation of neural network homeostasis,
diverse pharmacological agents with a presynaptic mode of action
were reported to be effective in the treatment of epilepsy. In
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particular drugs which provide rapid adaptation against exces-
sive excitation, e.g., via use-dependent inhibition of Nav or Cav
channels (phenytoin, carbamazepine, lamotrigine, topiramate,
and levetiracetam), likely act primarily in axons (Stefani et al.,
1996; Wu et al., 1998; Catterall, 1999; Vogl et al., 2012). Inter-
estingly, these drugs also have effects on psychiatric symptoms
(Barbosa et al., 2003; Lexi-Comp, 2009; Andrus and Gilbert,
2010) indicating common underlying mechanisms of cognitive
dysfunction and psychiatric symptoms of epilepsy. With more
research on neuron type-specific roles in behavior (Lovett-Barron
et al., 2014; Winkelmann et al., 2014), new antiepileptic strategies
could ground on these insights and specifically target presynaptic
molecules in the affected cell types.
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